Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Metformin Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease

This study has been completed.
Information provided by (Responsible Party):
Xiang Guang-da, Wuhan General Hospital of Guangzhou Military Command Identifier:
First received: June 11, 2013
Last updated: August 15, 2015
Last verified: August 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2015
  Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)